Skip to main content
Clinical Trials/ISRCTN26123577
ISRCTN26123577CompletedNot Applicable

Prophylactic Gabapentin for Prevention of Acute Mountain Sickness: a double blind, randomised, placebo controlled, clinical trial

Tehran University of Medical Sciences (Iran)0 sites204 target enrollmentStarted: March 27, 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
204

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Age of 15 to 65 years
  • 2. Ascent to a high altitude of 3500 to 3900 metres above sea level from an altitude of at least 1500 metres using cable cars (within 45 to 90 minutes)
  • 3. Consenting participant
  • 4. May reasonably be expected to complete a 24 hour trial

Exclusion Criteria

  • 1. Severe cardiac, pulmonary, or liver disease
  • 2. Severely impaired kidney function
  • 3. Current history of alcohol or drug abuse
  • 4. Pregnancy
  • 4. Known allergy to gabapentin
  • 5. Treatment with anticonvulsants or tricyclic antidepressants

Investigators

Sponsor
Tehran University of Medical Sciences (Iran)

Similar Trials

Prophylactic Gabapentin for Prevention of... | Clinical Trial